Stay updated on RGX-111 Gene Therapy in MPS I Clinical Trial
Sign up to get notified when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.

Latest updates to the RGX-111 Gene Therapy in MPS I Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of RGX-111 and Mucopolysaccharidosis Type I (MPS I), while adding new terminology related to the study's design and version revision.SummaryDifference24%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check59 days agoChange DetectedDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check80 days agoChange DetectedDifference0.1%
Stay in the know with updates to RGX-111 Gene Therapy in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGX-111 Gene Therapy in MPS I Clinical Trial page.